Provided by Tiger Fintech (Singapore) Pte. Ltd.

Syndax Pharmaceuticals

10.25
-0.4200-3.94%
Post-market: 10.250.00000.00%16:31 EDT
Volume:1.31M
Turnover:13.45M
Market Cap:881.99M
PE:-2.66
High:10.58
Open:10.44
Low:10.05
Close:10.67
Loading ...
Oct 02, 2023

Major Issues Report

Form 8-K - Current report
Aug 09, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 03, 2023

Major Issues Report

Form 8-K - Current report
Aug 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 02, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 24, 2023

Major Issues Report

Form 8-K - Current report
Jul 10, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 09, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 26, 2023

Major Issues Report

Form 8-K - Current report
May 18, 2023

Major Issues Report

Form 8-K - Current report
May 09, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 08, 2023

Major Issues Report

8-K - Current report
May 08, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 30, 2023

Major Issues Report

8-K - Current report
Feb 28, 2023

Major Issues Report

8-K - Current report
Feb 28, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals